Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission (Q33370115)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission |
scientific article |
Statements
1 reference
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission (English)
1 reference
Joanna Lambert
1 reference
René H Verheijen
1 reference
Leon F Massuger
1 reference
Benedict B Benigno
1 reference
Agamemnon A Epenetos
1 reference
Alberto Lopes
1 reference
John T Soper
1 reference
Janica Markowska
1 reference
Rostislav Vyzula
1 reference
Tom Jobling
1 reference
Gordon Stamp
1 reference
Gregory Spiegel
1 reference
Dennis Thurston
1 reference
Theo Falke
1 reference
Michael V Seiden
1 reference
1 February 2006
1 reference
1 reference
Identifiers
1 reference